NERV Stock Price | Minerva Neurosciences Inc P/E, Revenue, EPS, & Forecasts

Minerva Neurosciences Inc • NERV

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Minerva Neurosciences Inc

Ticker

NERV

Trading on

NASDAQ

ISIN

US6033802058

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Remy Luthringer Ph.D.

Headquarters

1500 District Avenue, Burlington, MA, United States, 01803

Employees

Website

minervaneurosciences.com

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Metrics

BasicAdvanced

Market cap

$28M

P/E ratio

EPS

-$1.85

Dividend Yield

0.00%

Beta

-0.42

Forward P/E ratio

11.21

EBIDTA

$-14.6M

Ex dividend date

Price & volume

Market cap

$28M

Average daily volume

7.9M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

11.21

PEG ratio

Trailing P/E

Price to sales

1.87

Price to book

2.68

Earnings

EPS

-$1.85

EPS estimate (current quarter)

-$0.35

EPS estimate (next quarter)

-$0.11

EBITDA

$-14.6M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

-0.42

52-week High

$6.41

52-week Low

$1.15

50-day moving average

$2.93

200-day moving average

$2.09

Short ratio

0.05

Short %

9.48%

Management effectiveness

ROE (TTM)

-675.09%

ROA (TTM)

-25.82%

Profit margin

0.00%

Gross profit margin

$-5.6M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

Float

5.4M

Insiders %

22.26%

Institutions %

28.26%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$4.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.56

-$1.05

46.67%

Q4 • 24Beat

-$0.50

-$1.07

53.27%

Q1 • 25Beat

-$0.43

-$0.90

52.22%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-3.3M

-∞%

Q2 • 25

$0M

$-2.7M

-∞%

Q3 • 25

NaN%

-15.79%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$30.4M

$62.5M

205.55%

Q2 • 25

$28.1T

$62.7T

223.10%

Q3 • 25

92,348,288.68%

100,229,336.46%

8.53%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-6.11T

$0M

$-6.11T

Q2 • 25

$-2.92T

$0M

$-45.2B

$-2.92T

Q3 • 25

-52.31%

NaN%

-52.31%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Minerva Neurosciences Inc share?

Minerva Neurosciences Inc shares are currently traded for undefined per share.

How many shares does Minerva Neurosciences Inc have?

Minerva Neurosciences Inc currently has 7M shares.

Does Minerva Neurosciences Inc pay dividends?

No, Minerva Neurosciences Inc doesn't pay dividends.

What is Minerva Neurosciences Inc 52 week high?

Minerva Neurosciences Inc 52 week high is $6.41.

What is Minerva Neurosciences Inc 52 week low?

Minerva Neurosciences Inc 52 week low is $1.15.

What is the 200-day moving average of Minerva Neurosciences Inc?

Minerva Neurosciences Inc 200-day moving average is $2.09.

Who is Minerva Neurosciences Inc CEO?

The CEO of Minerva Neurosciences Inc is Dr. Remy Luthringer Ph.D..

How many employees Minerva Neurosciences Inc has?

Minerva Neurosciences Inc has 8 employees.

What is the market cap of Minerva Neurosciences Inc?

The market cap of Minerva Neurosciences Inc is $28M.

What is the P/E of Minerva Neurosciences Inc?

The current P/E of Minerva Neurosciences Inc is null.

What is the EPS of Minerva Neurosciences Inc?

The EPS of Minerva Neurosciences Inc is -$1.85.

What is the PEG Ratio of Minerva Neurosciences Inc?

The PEG Ratio of Minerva Neurosciences Inc is 0.

What do analysts say about Minerva Neurosciences Inc?

According to the analysts Minerva Neurosciences Inc is considered a hold.